Erectile Dysfunction Market to Surge Past US$ 4.3 Billion by 2024 with North America Positioned as Growth Engine - Coherent Market Insights

The Global Erectile Dysfunction Market was valued at US$ 4,129.5 million in 2015 and is projected to expand at a CAGR of 0.2% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Growing prevalence of sexual disease and increasing geriatric population are major factor expected to drive growth of the global erectile dysfunction market.

Erectile dysfunction was earlier believed to be a condition mainly prevalent among elderly men. However, a recent study conducted by medical institution across the globe, explains that the erectile dysfunction also affects younger men, due to sex hormone imbalance at the early stage of their puberty. There are many medications available to treat erectile dysfunction that are especially effective among young men, as they are can easily absorb the drugs content and show quick effects when compared to men aged above 60 years.  Erectile dysfunction may involve several different medical conditions of reproductive health and sexual dysfunction. Attaining an erection is a one of the multipart process which involves the brain, sex hormones, nerves, muscles, and blood circulation and any deviation or interference from the normal erection process may lead to erectile dysfunction. In some cases at older age of 55-60 years, ED shows a multiple health problem such as cardiovascular problems, which necessitates immediate treatment, as this may also cause a risk factors for heart attacks and strokes.

To know the latest trends and insights prevalent in the erectile dysfunction market, click the link below:

https://www.coherentmarketinsights.com/market-insight/erectile-dysfunction-market-200

Complete erectile dysfunction is observed among around 5% men aged 40 years and above, the percent for which increases with age, recording an average of around 15% men aged 70 years and above. Whereas, mild or moderate erectile dysfunction is observed among 10% men aged between 50 years and 70 years. The geriatric population is highly susceptible to several health conditions due to weak immunity, hormonal changes are thus susceptible due to medication intake among this population, in turn, resulting in sexual inability and erectile dysfunction. According to Medical Journal of Sexual Medicine, erectile dysfunction can occur at any age, though it is more prominent among men aged 60 years and above. Medication such as Cialis and Viagra are highly prescribed drugs, increasing demand for which, is driving growth of the erectile dysfunction market.

Asia Pacific accounts for the highest populated region globally, witnesses increasing prevalence of male sexual dysfunction, which in turn, is boosting demand for sexual dysfunction medication. For instance, in 2011, the prevalence percentage of erectile dysfunction in China was 45%, South Korea 32.3%, Malaysia 26.8%, Thailand 37.5%, and Singapore 51.5%. According to UK Health Center, 1 in 10 men worldwide suffer from erectile dysfunction and over half of all men suffering from diabetes suffer from erectile dysfunction. Over 20 million people globally are prescribed Viagra to treat erectile dysfunction, from which 66% are successfully able to have sexual intercourse. Around 48% of this group suffer from one or more side-effects from Viagra.

Key takeaways of the erectile dysfunction market:

• The global erectile dysfunction market is expected to expand at a CAGR of 0.2% during the forecast period (2016–2024) as there still exists a major unrealized market, especially in Africa and Middle East countries.
• The Cialis product dominates the erectile dysfunction market in by product segment as it is the primary drug prescribed by many physicians globally because of high therapeutic efficacy and lower price
• Some of the major players involved in global erectile dysfunction market are Meda Pharmaceuticals, Inc, Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical System, Boston Scientific Corporation, and Vivus, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]